The Cooper Companies (COO) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
24 Feb, 2026Executive summary
Annual meeting scheduled for April 7, 2026, at the company’s headquarters in San Ramon, California.
Shareholders are invited to vote on key proposals, including director elections, auditor ratification, and executive compensation.
Voting matters and shareholder proposals
Election of nine directors, with each nominee recommended for approval by the board.
Ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending October 31, 2026.
Advisory vote to approve the compensation of named executive officers.
Board of directors and corporate governance
Board recommends all director nominees for election.
Director slate includes Colleen E. Jay, Barbara A. Carbone, Lawrence E. Kurzius, Cynthia L. Lucchese, Teresa S. Madden, Maria Rivas, M.D., Walter M Rosebrough, Jr., Robert S. Weiss, and Albert G. White III.
Latest events from The Cooper Companies
- Q1 2026 saw 6% revenue growth, raised FY26 guidance, and strong cash flow and share buybacks.COO
Q1 20266 Mar 2026 - Strong 2025 results, expanded buybacks, and robust governance set the stage for 2026 growth.COO
Proxy Filing24 Feb 2026 - Contact lens growth accelerates on capacity gains and premium demand, with margins set to improve.COO
Jefferies Global Healthcare Conference1 Feb 2026 - FY24 guidance raised as growth, innovation, and market leadership drive a positive outlook.COO
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Q3 revenue up 8% to $1.0B, net income up 23%, and full-year guidance raised.COO
Q3 202423 Jan 2026 - Double-digit growth, margin gains, and strong guidance highlight sustained momentum.COO
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Growth in vision and fertility, innovation in myopia control, and focus on free cash flow.COO
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - FY26 guidance, innovation, and strategic review support growth in expanding healthcare markets.COO
44th Annual J.P. Morgan Healthcare Conference15 Jan 2026 - Record revenues, margin expansion, and strong 2025 growth outlook despite headwinds.COO
Q4 202411 Jan 2026